Showing results (51-60 of 208) with videos related to
Sort By:
Pageof 21
Critical Care Medicine|March 29, 2024
Clinical Efficacy of Beta-1 Selective Beta-Blockers Versus Propranolol in Patients With Thyroid Storm: A Retrospective Cohort StudyYuichiro Matsuo, Taisuke Jo, Hideaki Watanabe, et al.Clinical Drug Investigation|November 7, 2024
Cost-Effectiveness Analysis of Adjuvant Pertuzumab and Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer in JapanChanon Nusawat, So Sato, Hideaki Watanabe, et al.Organic Letters|January 16, 2007
Enantioselective total synthesis of (-)-erinacine BHideaki Watanabe, Masashi Takano, Akinori Umino, et al.Journal of Pediatric Orthopedics|June 29, 2021
Clinical Results of Corrective Cast and Brace Treatment for Early-onset Scoliosis: The Effectiveness of Long-term Cast Treatment That Extends into Children's SchooldaysRyo Sugawara, Ichiro Kikkawa, Hideaki Watanabe, et al.Heliyon|June 2, 2023
Concentric hypertrophy geometry is a significant determinant of impaired global longitudinal strain in patients with normal cardiac structure and functionRyuichiro Anan, Tatsuya Imoto, Kumi Onizuka, et al.The Journal of Clinical Endocrinology and Metabolism|March 28, 2024
Potassium Iodide Use and Patient Outcomes for Thyroid Storm: An Observational StudyYuichiro Matsuo, Atsushi Miyawaki, Hideaki Watanabe, et al.Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|July 28, 2023
Radiation exposure in pediatric patients with early onset scoliosis: A longitudinal single-center studyRyo Sugawara, Hideaki Watanabe, Naoya Taki, et al.Journal of Pediatric Orthopedics. Part B|March 2, 2016
Radiological results of treatment using an extensive anterolateral approach for developmental dysplasia of the hip: minimum 5-year follow-upRyo Sugawara, Hideaki Watanabe, Kayo Hagiwara, et al.Surgical Neurology|November 13, 2007
Postoperative temporary neurological deficits in adults with moyamoya diseaseShiro Ohue, Yoshiaki Kumon, Kanehisa Kohno, et al.The Journal of Dermatology|June 23, 2007
Vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK 222584 inhibits both the induction and elicitation phases of contact hypersensitivityAisaku Yamamoto, Hideaki Watanabe, Hirohiko Sueki, et al.Pageof 21